A dipeptidyl peptidase-IV inhibitor improves hepatic steatosis and insulin resistance by AMPK-dependent and JNK-dependent inhibition of LECT2 expression

Published 2015 View Full Article

Authors

Keywords

Hepatokine, Dipeptidyl peptidase-4 inhibitor, Nonalcoholic fatty liver disease, AMP-activated protein kinase, c-Jun N-terminal kinase

Journal

BIOCHEMICAL PHARMACOLOGY

Volume 98, Issue 1, Pages 157-166

Publisher

Elsevier BV

Online

2015-08-20

DOI

10.1016/j.bcp.2015.08.098

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now